Chemed Total Liabilities 2012-2025 | CHE
Chemed total liabilities from 2012 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Chemed total liabilities for the quarter ending December 31, 2025 were $0.547B, a 2.48% increase year-over-year.
- Chemed total liabilities for 2024 were $0.55B, a 1.9% decline from 2023.
- Chemed total liabilities for 2023 were $0.56B, a 12.91% decline from 2022.
- Chemed total liabilities for 2022 were $0.643B, a 10.58% decline from 2021.
|
Chemed Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $550 |
| 2023 | $560 |
| 2022 | $643 |
| 2021 | $719 |
| 2020 | $534 |
| 2019 | $542 |
| 2018 | $384 |
| 2017 | $380 |
| 2016 | $356 |
| 2015 | $339 |
| 2014 | $409 |
| 2013 | $445 |
| 2012 | $406 |
| 2011 | $382 |
|
Chemed Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $547 |
| 2025-06-30 | $519 |
| 2025-03-31 | $545 |
| 2024-12-31 | $550 |
| 2024-09-30 | $534 |
| 2024-06-30 | $528 |
| 2024-03-31 | $544 |
| 2023-12-31 | $560 |
| 2023-09-30 | $543 |
| 2023-06-30 | $553 |
| 2023-03-31 | $551 |
| 2022-12-31 | $643 |
| 2022-09-30 | $635 |
| 2022-06-30 | $628 |
| 2022-03-31 | $639 |
| 2021-12-31 | $719 |
| 2021-09-30 | $538 |
| 2021-06-30 | $513 |
| 2021-03-31 | $529 |
| 2020-12-31 | $534 |
| 2020-09-30 | $566 |
| 2020-06-30 | $540 |
| 2020-03-31 | $594 |
| 2019-12-31 | $542 |
| 2019-09-30 | $560 |
| 2019-06-30 | $476 |
| 2019-03-31 | $482 |
| 2018-12-31 | $384 |
| 2018-09-30 | $411 |
| 2018-06-30 | $372 |
| 2018-03-31 | $406 |
| 2017-12-31 | $380 |
| 2017-09-30 | $418 |
| 2017-06-30 | $457 |
| 2017-03-31 | $386 |
| 2016-12-31 | $356 |
| 2016-09-30 | $355 |
| 2016-06-30 | $391 |
| 2016-03-31 | $398 |
| 2015-12-31 | $339 |
| 2015-09-30 | $409 |
| 2015-06-30 | $407 |
| 2015-03-31 | $419 |
| 2014-12-31 | $409 |
| 2014-09-30 | $437 |
| 2014-06-30 | $397 |
| 2014-03-31 | $423 |
| 2013-12-31 | $445 |
| 2013-09-30 | $455 |
| 2013-06-30 | $418 |
| 2013-03-31 | $416 |
| 2012-12-31 | $406 |
| 2012-09-30 | $390 |
| 2012-06-30 | $384 |
| 2012-03-31 | $397 |
| 2011-12-31 | $382 |
| 2011-09-30 | $389 |
| 2011-06-30 | $361 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |